Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution in Children and Adolescents: An 8-Week Phase 3 Study
Preservative- and phosphate-free bilastine 0.6% ophthalmic solution with sodium hyaluronate was safe and well-tolerated in pediatric patients aged >2 years after a once-daily, 8-week treatment, with a safety profile comparable to that of placebo.
Authors
- Eva Lasa Luaces
- Amalia Leceta
- Clara Padró-Casas
- Cristina Martínez Ostalé
- Pablo Durán-Pérez
- Inmaculada Gilaberte
- Porfirio Fernández González
- Adelaida Sánchez Bacallao
- Teresa Garriga-Baraut
Institutions
- Hebron University (PS)
- Vall d'Hebron Institut de Recerca (ES)
- ENT and Allergy (US)
- Hospital Quirónsalud Barcelona (ES)
- Hospital Universitario Central de Asturias (ES)
- Faes Farma (Spain) (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
Publication Details
- Journal
- Journal of Investigational Allergology and Clinical Immunology
- Published
- 2026-03-27
- DOI
- https://doi.org/10.18176/jiaci.1169
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00